Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Staging

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 185 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Tumor Markers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tumor Markers (online CE course)
Prostate-Specific Antigen (PSA): Clinical Applications in Prostate Cancer Staging

You may recall that one of the desired characteristics of an ideal tumor marker is to correlate with tumor mass and degree of metastasis. In this respect, PSA serves as an effective tool to help assess the stage of prostate cancer. Higher PSA levels strongly correlate with tumor mass and metastasis. PSA levels greater than 50 µg/L are highly indicative of an advanced stage of prostate cancer. Similarly, patients with less than 20 µg/L of PSA seldom have bone metastases.2